Literature DB >> 9516470

The nucleolin binding activity of hepatitis delta antigen is associated with nucleolus targeting.

C H Lee1, S C Chang, C J Chen, M F Chang.   

Abstract

Hepatitis delta antigens (HDAgs) are important for the replication and assembly of hepatitis delta virus (HDV). To understand the association between HDAgs and cellular proteins and the mechanism of viral multiplication, we have studied the interaction between HDAgs and nucleolin, a major nucleolar phosphoprotein. The interaction between HDAgs and nucleolin was first demonstrated by immunofluorescence staining studies. HDAgs and endogenous nucleolin were colocalized in the nucleoli of cultured cells transfected with plasmids encoding the small and large HDAg. Coimmunoprecipitation results indicated that the NH2-terminal domain of HDAg was essential for its binding to nucleolin. In vitro ligand binding assays revealed two nucleolin binding sites, NBS1 and NBS2. Each spanned amino acid residues 35-50 and 51-65, respectively, with a conserved core sequence K(K/R)XK. HDV replication was modulated by exogenous human nucleolin. In addition, a small HDAg mutant S-d65/75, which possesses both NBS1 and NBS2, was capable of transactivating HDV replication, whereas the small HDAg mutant S-d50/75, which retained NBS1 but not NBS2, was unable to support the replication of HDV. Thus, the nucleolin binding activity of HDAg is critical for its nucleolar targeting and is involved in the modulation of HDV replication.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9516470     DOI: 10.1074/jbc.273.13.7650

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Interactions between hepatitis delta virus proteins.

Authors:  G Moraleda; K Dingle; P Biswas; J Chang; H Zuccola; J Hogle; J Taylor
Journal:  J Virol       Date:  2000-06       Impact factor: 5.103

2.  RNA-Dependent replication and transcription of hepatitis delta virus RNA involve distinct cellular RNA polymerases.

Authors:  L E Modahl; T B Macnaughton; N Zhu; D L Johnson; M M Lai
Journal:  Mol Cell Biol       Date:  2000-08       Impact factor: 4.272

Review 3.  RNA replication without RNA-dependent RNA polymerase: surprises from hepatitis delta virus.

Authors:  Michael M C Lai
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

4.  Novel nuclear export signal-interacting protein, NESI, critical for the assembly of hepatitis delta virus.

Authors:  Yun-Hsin Wang; Shin C Chang; Cheng Huang; Ya-Ping Li; Chia-Huei Lee; Ming-Fu Chang
Journal:  J Virol       Date:  2005-07       Impact factor: 5.103

5.  Large hepatitis delta antigen is a novel clathrin adaptor-like protein.

Authors:  Cheng Huang; Shin C Chang; I-Chen Yu; Yeou-Guang Tsay; Ming-Fu Chang
Journal:  J Virol       Date:  2007-03-21       Impact factor: 5.103

6.  Nucleolar targeting of hepatitis delta antigen abolishes its ability to initiate viral antigenomic RNA replication.

Authors:  Wen-Hung Huang; Yen-Shun Chen; Pei-Jer Chen
Journal:  J Virol       Date:  2007-11-07       Impact factor: 5.103

7.  Clathrin-mediated post-Golgi membrane trafficking in the morphogenesis of hepatitis delta virus.

Authors:  Cheng Huang; Shin C Chang; Hui-Chin Yang; Chung-Liang Chien; Ming-Fu Chang
Journal:  J Virol       Date:  2009-09-30       Impact factor: 5.103

8.  Rolling circle replication of hepatitis delta virus RNA is carried out by two different cellular RNA polymerases.

Authors:  Thomas B Macnaughton; Stephanie T Shi; Lucy E Modahl; Michael M C Lai
Journal:  J Virol       Date:  2002-04       Impact factor: 5.103

9.  Combined proteomic-RNAi screen for host factors involved in human hepatitis delta virus replication.

Authors:  Dan Cao; Dirk Haussecker; Yong Huang; Mark A Kay
Journal:  RNA       Date:  2009-09-23       Impact factor: 4.942

10.  Nucleolin: acharan sulfate-binding protein on the surface of cancer cells.

Authors:  Eun Ji Joo; Gerdy B ten Dam; Toin H van Kuppevelt; Toshihiko Toida; Robert J Linhardt; Yeong Shik Kim
Journal:  Glycobiology       Date:  2004-08-25       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.